Neutropenia Nutrition Product Market

Sterile / UHT RTD nutrition is projected at 47.0% of product type in 2026, with mild-moderate at 56.4% of neutropenia severity and RTD at 56.2% of product form. Demand centers on maintaining oral intake during intensive cancer care, and conflicting diet evidence narrows broad infection-prevention positioning.